FBTCX vs. THISX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class C (FBTCX) and T. Rowe Price Health Sciences Fund Class I (THISX).
FBTCX is managed by Fidelity. It was launched on Dec 27, 2000. THISX is an actively managed fund by T. Rowe Price. It was launched on Dec 29, 1995.
Performance
FBTCX vs. THISX - Performance Comparison
Loading graphics...
FBTCX vs. THISX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBTCX Fidelity Advisor Biotechnology Fund Class C | -2.86% | 38.48% | -2.00% | 9.86% | -8.64% | -3.72% | 31.17% | 24.82% | -4.55% | 23.33% |
THISX T. Rowe Price Health Sciences Fund Class I | -9.61% | 17.92% | 16.75% | 3.17% | -12.11% | 13.62% | 30.35% | 38.29% | 1.20% | 26.96% |
Returns By Period
In the year-to-date period, FBTCX achieves a -2.86% return, which is significantly higher than THISX's -9.61% return.
FBTCX
- 1D
- -0.75%
- 1M
- -6.13%
- YTD
- -2.86%
- 6M
- 10.98%
- 1Y
- 41.66%
- 3Y*
- 15.08%
- 5Y*
- 5.77%
- 10Y*
- 9.77%
THISX
- 1D
- 0.37%
- 1M
- -9.32%
- YTD
- -9.61%
- 6M
- 4.41%
- 1Y
- 6.58%
- 3Y*
- 9.52%
- 5Y*
- 5.15%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTCX vs. THISX - Expense Ratio Comparison
FBTCX has a 1.75% expense ratio, which is higher than THISX's 0.67% expense ratio.
Return for Risk
FBTCX vs. THISX — Risk / Return Rank
FBTCX
THISX
FBTCX vs. THISX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and T. Rowe Price Health Sciences Fund Class I (THISX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBTCX | THISX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.52 | 0.33 | +1.19 |
Sortino ratioReturn per unit of downside risk | 2.06 | 0.58 | +1.48 |
Omega ratioGain probability vs. loss probability | 1.26 | 1.07 | +0.19 |
Calmar ratioReturn relative to maximum drawdown | 2.31 | 0.42 | +1.89 |
Martin ratioReturn relative to average drawdown | 9.25 | 1.23 | +8.01 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBTCX | THISX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.52 | 0.33 | +1.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.25 | 0.28 | -0.03 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.63 | -0.36 |
Correlation
The correlation between FBTCX and THISX is 0.85, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FBTCX vs. THISX - Dividend Comparison
FBTCX's dividend yield for the trailing twelve months is around 1.73%, less than THISX's 13.56% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTCX Fidelity Advisor Biotechnology Fund Class C | 1.73% | 1.68% | 0.00% | 0.00% | 0.00% | 24.50% | 9.78% | 7.92% | 2.92% | 0.00% | 0.00% | 5.73% |
THISX T. Rowe Price Health Sciences Fund Class I | 13.56% | 12.25% | 26.10% | 5.20% | 1.76% | 7.62% | 7.25% | 12.58% | 6.70% | 7.55% | 0.00% | 0.00% |
Drawdowns
FBTCX vs. THISX - Drawdown Comparison
The maximum FBTCX drawdown since its inception was -64.04%, which is greater than THISX's maximum drawdown of -28.97%. Use the drawdown chart below to compare losses from any high point for FBTCX and THISX.
Loading graphics...
Drawdown Indicators
| FBTCX | THISX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.04% | -28.97% | -35.07% |
Max Drawdown (1Y)Largest decline over 1 year | -13.63% | -12.78% | -0.85% |
Max Drawdown (5Y)Largest decline over 5 years | -37.26% | -27.53% | -9.73% |
Max Drawdown (10Y)Largest decline over 10 years | -39.37% | — | — |
Current DrawdownCurrent decline from peak | -7.46% | -12.46% | +5.00% |
Average DrawdownAverage peak-to-trough decline | -23.21% | -7.18% | -16.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.16% | 4.37% | -0.21% |
Volatility
FBTCX vs. THISX - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class C (FBTCX) has a higher volatility of 7.76% compared to T. Rowe Price Health Sciences Fund Class I (THISX) at 5.30%. This indicates that FBTCX's price experiences larger fluctuations and is considered to be riskier than THISX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBTCX | THISX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.76% | 5.30% | +2.46% |
Volatility (6M)Calculated over the trailing 6-month period | 16.37% | 10.70% | +5.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.57% | 18.41% | +7.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.40% | 18.29% | +5.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.62% | 19.99% | +4.63% |